Bayer CropScience Ltd - Stock Valuation and Financial Performance

BSE: 506285 | NSE: BAYERCROP | Pesticides & Agrochemicals | Small Cap

Bayer CropScience Share Price

5,264.35 -25.55 -0.48%
as on 28-Mar'24 16:01

DeciZen - make an informed investing decision on Bayer CropScience

Overall Rating
Bole Toh

1. Quality

2. Valuation

Fair

3. Price Trend

Bayer CropScience stock performance -

mw4me loader
P/E Ratio (SA):
29.34
Market Cap:
23,563.4 Cr.
52-wk low:
3,922.8
52-wk high:
6,202

Is Bayer CropScience Ltd an attractive stock to invest in?

1. Is Bayer CropScience Ltd a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Bayer CropScience Ltd is a good quality company.

2. Is Bayer CropScience Ltd undervalued or overvalued?

The key valuation ratios of Bayer CropScience Ltd's currently when compared to its past seem to suggest it is in the Fair zone.

3. Is Bayer CropScience Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Bayer CropScience Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Bayer CropScience:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Bayer CropScience Ltd has performed well in majority of the past ten years indicating its past ten year financial track record is very good

Value Creation

Value Creation Index Colour Code Guide

Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
ROCE % 16.2%20.6%16.8%15.3%16.3%17.4%23.7%19.1%23.9%26.5%-
Value Creation
Index
0.20.50.20.10.20.30.80.70.81.0-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 3,2453,7232,7692,8032,7103,1673,6094,2614,7345,1405,294
Sales YoY Gr.-14.7%-25.6%1.2%-3.3%16.9%14%18.1%11.1%8.6%-
Adj EPS 80.2105.289.883.288.599.7124.9106.8133.1150.8178.7
YoY Gr.-31.1%-14.6%-7.4%6.4%12.6%25.3%-14.5%24.7%13.3%-
BVPS (₹) 476555.4519.6581518.5649.8572.9568562.2604717.5
Adj Net
Profit
294385317294304342561480598678803
Cash Flow from Ops. 282200207157121433666687216609-
Debt/CF from Ops. 0000000000-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 5.2%13.7%12.5%8.6%
Adj EPS 7.3%11.3%6.5%13.3%
BVPS2.7%3.1%1.8%7.4%
Share Price 13.8% 3.7% 1.8% 31.3%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
Return on
Equity %
1620.416.415.115.81723.318.723.625.927
Op. Profit
Mgn %
12.713.915.814.915.315.420.21917.117.920.1
Net Profit
Mgn %
9.110.311.510.511.210.815.611.312.613.215.2
Debt to
Equity
0000000000-
Working Cap
Days
244238326357439411389345349359151
Cash Conv.
Cycle
63651011101311018174778783

Recent Performance Summary

Return on Equity has increased versus last 3 years average to 27.00%

Sales growth is growing at healthy rate in last 3 years 12.50%

Net Profit has been subdued in last 3 years 6.48%

Sales growth is not so good in last 4 quarters at 2.43%

Latest Financials - Bayer CropScience Ltd.

Standalone Consolidated
TTM EPS (₹) 178.7 12.3
TTM Sales (₹ Cr.) 5,294 783
BVPS (₹.) 717.5 0
Reserves (₹ Cr.) 3,180 294
P/BV 7.31 0.00
PE 29.34 425.26
From the Market
52 Week Low / High (₹) 3922.75 / 6202.00
All Time Low / High (₹) 34.13 / 6550.00
Market Cap (₹ Cr.) 23,563
Equity (₹ Cr.) 44.9
Face Value (₹) 10
Industry PE 33.6

Management X-Ray of Bayer CropScience:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Bayer CropScience

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Sales3,2453,7232,7692,8032,7103,1673,6094,2614,7345,140
Operating Expenses 2,8403,2112,3352,3912,3012,6872,8843,4523,9294,225
Manufacturing Costs101136288189114200204268277282
Material Costs2,0602,3881,4321,5731,5441,5771,8222,3212,5362,693
Employee Cost 204227221246264364362362463534
Other Costs 476460394383379545497501653716
Operating Profit 405512434412409481726810806915
Operating Profit Margin (%) 12.5%13.8%15.7%14.7%15.1%15.2%20.1%19.0%17.0%17.8%
Other Income 91918272395367666073
Interest 55107111014131322
Depreciation 50252529334465746580
Exceptional Items 000000-130559104
Profit Before Tax 441574482448404480583795847990
Tax 151191167157104143109301202232
Profit After Tax 290383315291300337475493645758
PAT Margin (%) 8.9%10.3%11.4%10.4%11.1%10.6%13.1%11.6%13.6%14.8%
Adjusted EPS (₹)79.1104.689.082.287.598.3105.7109.8143.7168.9
Dividend Payout Ratio (%)7%20%19%21%21%18%24%105%104%77%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23

Equity and Liabilities

Shareholders Fund 1,7422,0331,8392,0571,7782,2292,5732,5502,5242,712
Share Capital 37373535343445454545
Reserves 1,7061,9961,8042,0211,7442,1952,5282,5052,4792,667
Minority Interest0000000000
Debt0000002000
Long Term Debt0000000000
Short Term Debt0000002000
Trade Payables287268204287284644475830820873
Others Liabilities 1,4321,7441,6932,0812,1682,6642,8793,2263,6183,931
Total Liabilities 3,4624,0443,7374,4254,2305,5375,9286,6076,9627,516

Fixed Assets

Gross Block479434314361384548635649713764
Accumulated Depreciation237112245080139197254272328
Net Fixed Assets242322290311304409438395441437
CWIP 217117243647567698109
Investments 42936500041523941
Inventories5505656657687401,1579641,3251,5121,807
Trade Receivables4105714055576596997187551,005976
Cash Equivalents 4861,1307638394185821,0711,210787868
Others Assets1,5541,4271,5601,8772,0732,6432,6412,7943,0793,278
Total Assets 3,4624,0443,7374,4254,2305,5375,9286,6076,9627,516

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Cash Flow From Operating Activity 282200207157121433666687216609
PBT 441574482448404480583795847990
Adjustment -2-16-225386719162390
Changes in Working Capital 3-167-87-148-2259028-7-406-141
Tax Paid -160-191-165-148-95-205-136-163-264-240
Cash Flow From Investing Activity -29048516-838-415-2976483
Capex -15997-37-49-42-55-28-31-47-73
Net Investments 0-25-11-1350-396-40-12310
Others -13141464543036393988146
Cash Flow From Financing Activity -480-42-590-73-581-158-148-556-703-613
Net Proceeds from Shares 0000000000
Net Proceeds from Borrowing 0000000000
Interest Paid -2-1-5-1-4-5-2-3-4-11
Dividend Paid -20-35-62-60-60-126-102-516-673-561
Others -458-6-523-12-517-27-44-37-26-41
Net Cash Flow -488644-36776-421-140489138-42479
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Ratios
ROE (%)15.7620.2916.2714.9415.6516.8319.7719.2525.4328.96
ROCE (%)24.2630.6325.3923.3521.6524.4124.831.533.8838.67
Asset Turnover Ratio11.040.740.720.640.720.720.770.80.82
PAT to CFO Conversion(x)0.970.520.660.540.41.281.41.390.330.8
Working Capital Days
Receivable Days39466260817163565961
Inventory Days5652788910099948695103
Payable Days4342605768107112103119115

Bayer CropScience Ltd Stock News

Bayer CropScience Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Bayer CropScience on 28-Mar-2024 16:01 is ₹5,264.4.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 28-Mar-2024 16:01 the market cap of Bayer CropScience stood at ₹23,563.4.
The latest P/E ratio of Bayer CropScience as of 28-Mar-2024 16:01 is 29.34.
The latest P/B ratio of Bayer CropScience as of 28-Mar-2024 16:01 is 7.31.
The 52-week high of Bayer CropScience is ₹6,202 and the 52-week low is ₹3,922.8.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Bayer CropScience is ₹5,294 ( Cr.) .

About Bayer CropScience Ltd

Bayer CropScience is the flagship company of the Bayer Group in India and is publicly listed on the Bombay Stock Exchange. It is engaged in manufacturing of crop protection products, non agricultural pest-control, seeds and plant biotechnology. The company enjoys a unique position in the market because of its capability to offer new innovative products, technologies, processes, services and business models. With its innovative products, it is contributing to finding solutions to some of the major challenges of its time. The company remains committed to improving lives by advancing nutrition and healthcare solutions for the country’s growing population.

Business area of the company

The company’s Crop Science division is the largest for Bayer in India with businesses in seeds & traits, crop protection, digital farming and environmental science (non-agricultural pest control). Its robust crop protection portfolio includes products to manage insects, pests, weeds and diseases. It also includes bilogical solutions, that use nature’s own defenses to protect crops. Its broad range of high-quality hybrid seeds includes cutting-edge traits for high-yielding crops with improved weed management and superior insect control. Its expertise and innovations in digital farming provide farmers with a deeper understanding of their fields so they can utilize their inputs and natural resources as efficiently as possible. The company also has products that focus on non-agricultural applications in the form of products and services for vector control and professional pest control.

The company’s Pharmaceuticals division in India operates as Bayer Zydus Pharma, a joint venture between Bayer and Zydus Cadila. The focus of this business is on prescription products, especially for cardiology and women’s health care and on specialty therapeutics in the areas of oncology, hematology and ophthalmology. The division also comprises the radiology business, which markets diagnostic imaging equipment together with the necessary contrast agents. Its Consumer Health division is focused on making self-care for a better life a reality for billions of people around the world through everyday healthcare. Its Animal Health business develops and markets products and solutions for the prevention and treatment of diseases in companion and farm animals.

Awards:

  • Bayer India wins ‘Aon Best Employer in India 2017’ award.
  • Bayer India wins ‘Aon Best Employer in India 2018’ award.
  • Bayer India wins the Mercer NDTV Employer Excellence Award 2018.
  • Bayer India wins ‘Aon Best Employer in India 2019’ award for the third time in a row.
  • Bayer received a 'Great Places to Work' certification.

Milestones:

  • 1863: The company is founded on August 1, 1863 by dye salesman Friedrich Bayer and the master dyer Johann Friedrich Weskott in Wuppertal, Germany - a 19th century startup with tremendous potential.
  • 1896: First wholly-owned subsidiary of Bayer in Asia ‘Farbenfabriken Bayer and Company Limited’ is set-up in Mumbai.
  • 1958: Bayer CropScience Ltd. – the listed entity for Bayer in India - was incorporated on September 9, 1958.
  • 1958: Bayer establishes Bayer Agrochem Private Limited in India.
  • 1963: The name of Bayer Agrochem changes to Bayer (India) Limited.
  • 1969: The company commences operations of a major plant in Thane.
  • 2001: Bayer acquires Aventis CropScience.
  • 2004: First Imidacloprid production facility outside Germany is inaugurated in Vapi.
  • 2005: Lanxess AG is spun off from the Bayer Group.
  • 2006: Takeover of Schering AG, Berlin, Germany.
  • 2011: Bayer Zydus Pharma is set up as a 50:50 joint venture between Bayer HealthCare and Zydus Cadilla.
  • 2013: The Seeds business unit (Bayer BioScience) of Bayer CropScience, India opens a multi-crop breeding station in Chandippa, near Hyderabad and a Mustard Breeding Station in Palwal, Haryana.
  • 2014: New Headquarters of Bayer South Asia inaugurated at Thane.
  • 2015: Bayer MaterialScience is now independent under the name Covestro.
  • 2016: In September, Bayer and Monsanto sign a binding merger agreement.
  • 2017: Bayer kicks off ‘LEAPS‘ globally as a new approach to complement the existing R&D capabilities and which aims to enable breakthrough innovations across healthcare and agriculture.
  • 2018: Bayer concludes process to sell Covestro.
  • 2019: Bayer completes Monsanto integration in India in September.
  • 2019: A new plant is inaugurated at Bayer‘s Himatnagar site, strengthening company’s manufacturing footprint in Gujarat.
  • 2020: FOGSI and Bayer Zydus Pharma collaborate to drive adoption of digital technology solution ‘Ask Tanu’.
  • 2020: Bayer’s Aflibercept injection (EyleaTM) for intravitreal use receives DCGI Approval for Diabetic Macular Edema Indication.
  • 2020: Bayer partners with ITC e-Choupal 4.0 to support farmers.
  • 2020: Bayer and Curadev sign research collaboration and license agreement to develop novel STING antagonists across indications.
Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.